nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0298	0.0311	CcSEcCtD
Reboxetine—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.0298	0.0311	CcSEcCtD
Reboxetine—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0272	CcSEcCtD
Reboxetine—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.0257	0.0268	CcSEcCtD
Reboxetine—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0237	0.0247	CcSEcCtD
Reboxetine—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.023	0.024	CcSEcCtD
Reboxetine—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.0227	0.0236	CcSEcCtD
Reboxetine—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0203	0.0212	CcSEcCtD
Reboxetine—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.0201	0.0209	CcSEcCtD
Reboxetine—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.0189	0.0197	CcSEcCtD
Reboxetine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0182	CcSEcCtD
Reboxetine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0163	0.017	CcSEcCtD
Reboxetine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0163	0.017	CcSEcCtD
Reboxetine—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0168	CcSEcCtD
Reboxetine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0165	CcSEcCtD
Reboxetine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0164	CcSEcCtD
Reboxetine—Mania—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0159	CcSEcCtD
Reboxetine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0154	CcSEcCtD
Reboxetine—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0144	CcSEcCtD
Reboxetine—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0141	CcSEcCtD
Reboxetine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0132	CcSEcCtD
Reboxetine—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0128	CcSEcCtD
Reboxetine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0126	CcSEcCtD
Reboxetine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0126	CcSEcCtD
Reboxetine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0122	CcSEcCtD
Reboxetine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0118	CcSEcCtD
Reboxetine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0118	CcSEcCtD
Reboxetine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0117	CcSEcCtD
Reboxetine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0112	CcSEcCtD
Reboxetine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00964	0.01	CcSEcCtD
Reboxetine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00955	0.00995	CcSEcCtD
Reboxetine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0087	0.00906	CcSEcCtD
Reboxetine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0081	0.00844	CcSEcCtD
Reboxetine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00807	0.00841	CcSEcCtD
Reboxetine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.008	0.00834	CcSEcCtD
Reboxetine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00788	0.00821	CcSEcCtD
Reboxetine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00779	0.00811	CcSEcCtD
Reboxetine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00767	0.00799	CcSEcCtD
Reboxetine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0075	0.00782	CcSEcCtD
Reboxetine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00745	0.00776	CcSEcCtD
Reboxetine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00737	0.00768	CcSEcCtD
Reboxetine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00729	0.0076	CcSEcCtD
Reboxetine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00712	0.00741	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00712	0.00741	CcSEcCtD
Reboxetine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00697	0.00726	CcSEcCtD
Reboxetine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00671	0.00699	CcSEcCtD
Reboxetine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00652	0.00679	CcSEcCtD
Reboxetine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00644	0.00671	CcSEcCtD
Reboxetine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00669	CcSEcCtD
Reboxetine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00631	0.00657	CcSEcCtD
Reboxetine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00622	0.00648	CcSEcCtD
Reboxetine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00622	0.00648	CcSEcCtD
Reboxetine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00604	0.0063	CcSEcCtD
Reboxetine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00596	0.00621	CcSEcCtD
Reboxetine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00611	CcSEcCtD
Reboxetine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00583	0.00608	CcSEcCtD
Reboxetine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00568	0.00592	CcSEcCtD
Reboxetine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0056	0.00583	CcSEcCtD
Reboxetine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00555	0.00579	CcSEcCtD
Reboxetine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00554	0.00577	CcSEcCtD
Reboxetine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00551	0.00574	CcSEcCtD
Reboxetine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00571	CcSEcCtD
Reboxetine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00547	0.0057	CcSEcCtD
Reboxetine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00543	CcSEcCtD
Reboxetine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0054	CcSEcCtD
Reboxetine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00528	CcSEcCtD
Reboxetine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00525	CcSEcCtD
Reboxetine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00524	CcSEcCtD
Reboxetine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00522	CcSEcCtD
Reboxetine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00509	CcSEcCtD
Reboxetine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00506	CcSEcCtD
Reboxetine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00477	0.00497	CcSEcCtD
Reboxetine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00496	CcSEcCtD
Reboxetine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00492	CcSEcCtD
Reboxetine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00463	0.115	CbGeAlD
Reboxetine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00474	CcSEcCtD
Reboxetine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00451	0.0047	CcSEcCtD
Reboxetine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00468	CcSEcCtD
Reboxetine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00465	CcSEcCtD
Reboxetine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00456	CcSEcCtD
Reboxetine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00455	CcSEcCtD
Reboxetine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00454	CcSEcCtD
Reboxetine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00453	CcSEcCtD
Reboxetine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00447	CcSEcCtD
Reboxetine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00445	CcSEcCtD
Reboxetine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00437	CcSEcCtD
Reboxetine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00431	CcSEcCtD
Reboxetine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00429	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00428	CcSEcCtD
Reboxetine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00426	CcSEcCtD
Reboxetine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00405	0.00421	CcSEcCtD
Reboxetine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.004	0.00417	CcSEcCtD
Reboxetine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0041	CcSEcCtD
Reboxetine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00394	0.098	CbGeAlD
Reboxetine—Shock—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00406	CcSEcCtD
Reboxetine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00405	CcSEcCtD
Reboxetine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00403	CcSEcCtD
Reboxetine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00401	CcSEcCtD
Reboxetine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00399	CcSEcCtD
Reboxetine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00394	CcSEcCtD
Reboxetine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00386	CcSEcCtD
Reboxetine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00374	CcSEcCtD
Reboxetine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00371	CcSEcCtD
Reboxetine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00368	CcSEcCtD
Reboxetine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00367	CcSEcCtD
Reboxetine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00364	CcSEcCtD
Reboxetine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00359	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00357	CcSEcCtD
Reboxetine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00353	CcSEcCtD
Reboxetine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0034	CcSEcCtD
Reboxetine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00338	CcSEcCtD
Reboxetine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00328	CcSEcCtD
Reboxetine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00327	CcSEcCtD
Reboxetine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00327	CcSEcCtD
Reboxetine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00304	CcSEcCtD
Reboxetine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00296	CcSEcCtD
Reboxetine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00283	CcSEcCtD
Reboxetine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00273	CcSEcCtD
Reboxetine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00263	CcSEcCtD
Reboxetine—Rash—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0026	CcSEcCtD
Reboxetine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0026	CcSEcCtD
Reboxetine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00259	CcSEcCtD
Reboxetine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00238	0.0592	CbGeAlD
Reboxetine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00245	CcSEcCtD
Reboxetine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00226	0.0561	CbGeAlD
Reboxetine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00199	0.0494	CbGeAlD
Reboxetine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.0019	0.0472	CbGeAlD
Reboxetine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00166	0.0413	CbGeAlD
Reboxetine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00148	0.0368	CbGeAlD
Reboxetine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.0014	0.0349	CbGeAlD
Reboxetine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00139	0.0345	CbGeAlD
Reboxetine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00125	0.031	CbGeAlD
Reboxetine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.0012	0.0299	CbGeAlD
Reboxetine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00118	0.0294	CbGeAlD
Reboxetine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00114	0.0283	CbGeAlD
Reboxetine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00109	0.0271	CbGeAlD
Reboxetine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00104	0.0259	CbGeAlD
Reboxetine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.001	0.0249	CbGeAlD
Reboxetine—HTR2C—brain—amyotrophic lateral sclerosis	0.000953	0.0237	CbGeAlD
Reboxetine—SLC6A4—brain—amyotrophic lateral sclerosis	0.000904	0.0225	CbGeAlD
Reboxetine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000854	0.0212	CbGeAlD
Reboxetine—SLC6A2—brain—amyotrophic lateral sclerosis	0.000796	0.0198	CbGeAlD
Reboxetine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000579	0.0144	CbGeAlD
Reboxetine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00057	0.0142	CbGeAlD
Reboxetine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000558	0.0139	CbGeAlD
Reboxetine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000549	0.0137	CbGeAlD
Reboxetine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000546	0.0136	CbGeAlD
Reboxetine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000536	0.0133	CbGeAlD
Reboxetine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000487	0.0121	CbGeAlD
Reboxetine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000436	0.0108	CbGeAlD
Reboxetine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.00041	0.0102	CbGeAlD
Reboxetine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000395	0.00982	CbGeAlD
Reboxetine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000386	0.0096	CbGeAlD
Reboxetine—ABCB1—brain—amyotrophic lateral sclerosis	0.000313	0.0078	CbGeAlD
